Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 1

Status

Completed 4Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1NETWORK 1INDUSTRY 1

Study Type

Observational 7Interventional 6

Sponsor

Cancer Type

Lymphoid 2Thoracic 1Sarcoma 1Gynecologic 1

Conditions

Breast Neoplasms 10180Neoplasms 7807Carcinoma, Non-Small-Cell Lung 5756Prostatic Neoplasms 5024Colorectal Neoplasms 4603Lung Neoplasms 3723Leukemia, Myeloid, Acute 3102Neoplasm Metastasis 3082Multiple Myeloma 3081Pancreatic Neoplasms 2843Melanoma 2651Ovarian Neoplasms 2573Lymphoma 2570Carcinoma, Hepatocellular 2479Stomach Neoplasms 2329Recurrence 2229Head and Neck Neoplasms 2102Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2057Leukemia 2013Brain Neoplasms 1902Glioblastoma 1795Colonic Neoplasms 1790Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1719Uterine Cervical Neoplasms 1693Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Follicular 1651Lymphoma, Large B-Cell, Diffuse 1597Carcinoma, Renal Cell 1577

Interventions

Vincristine 1VGX-3100 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Rituximab 1Prednisone 1Etoposide 1Electroporation Therapies 1Electroporation 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × HIV Seropositivity × Clear all
NCT03603808 2026-05-08

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

AIDS Malignancy Consortium

Phase 2 Completed
44 enrolled 15 charts
Gynecologic

Squamous Intraepithelial Lesions, HIV Seropositivity

NCT06919679 2025-04-09

BASTION

University of Cologne

Phase 2 Not yet recruiting
35 enrolled
Lymphoid

HIV Seropositivity, Hodgkin Disease

NCT02029430 2024-06-11

A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

ImmunityBio, Inc.

Phase 2 Completed
15 enrolled 9 charts
Sarcoma

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Neoplasms, Sarcoma, Sarcoma, Kaposi

NCT01092182 2023-04-27

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
194 enrolled 19 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, HIV Seropositivity, HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT01296113 2023-03-14

CHIVA

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Completed
61 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, HIV Seropositivity

NCT02302859 2020-01-27

Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

M.D. Anderson Cancer Center

Phase NA Terminated
8 enrolled 3 charts

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡